As outlined in Table 1, the new PCO recommends that when HBV screening is pursued, both HB surface antigen (HBsAg) and HB core antibody (anti-HBc) be tested. 10 It also recommends against screening ...
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group ...
In the seventeen month time period of this retrospective study, there were 11,719 HBsAg tests ordered for 9,930 patients (with some patients being tested two or more separate times during the time ...
Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...
- New point-of-care rapid test identifies and helps make effective care more accessible for millions of people living with hepatitis B, in support of World Health Organization (WHO) hepatitis targets ...
In clinical trials, bepirovirsen showed the potential to address a significant unmet medical need for patients with chronic hepatitis B by reducing hepatitis B surface antigen levels and HBV DNA. The ...
Hepatitis B core antibody (HBcAb) is the first antibody to appear following acute hepatitis B infection and will persist in high levels following resolution of infection and in chronically infected ...
Please provide your email address to receive an email when new articles are posted on . The highest percentages of patients with HBsAg loss were observed in the groups that received xalnesiran plus an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results